Utilization of TandemHeart in cardiogenic shock: Insights from the THEME registry.
Michael MegalyChaun GandolfoSamer ZakhourMei JiangKristie BurgessStanley ChetcutiMichael RagostaEric AdlerAndrew ColettiBrian P O'NeillKhaldoon AlaswadMir Babar BasirPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
In a contemporary cohort of patients presenting in CS, the use of TandemHeart is associated with a 74% 30-day survival and a 66% 180-day survival.